Lilly, Xanodyne Hid Darvocet Risks, Suit Says

Law360, New York (January 7, 2011, 4:09 PM EST) -- The parents of a woman who suffered a fatal heart attack after taking the painkiller Darvocet — which was later pulled from U.S. shelves — have accused Xanodyne Pharmaceuticals Inc. and Eli Lilly & Co. of concealing knowledge of the drug's defects.

The drugmakers intentionally defrauded the medical and health care community, the U.S. Food and Drug Administration and the general public by falsely advertising that Darvocet had been tested to be safe and effective for its indicated use, Tammy and John Gilbert allege in a...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.